超过5%股东持股披露「修订」
Ocular Therapeutix(OCUL)02-13 19:18
$Ocular Therapeutix(OCUL)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001493152-23-004374 Act: 34 Size: 88 KB 网页链接
| 今开：4.91 | 昨收：4.85 |
| 最高：5.01 | 最低：4.845 |
| 涨停价： | 跌停价： |
| 总市值：381344939 |
Ocular Therapeutix(OCUL)02-13 19:18
$Ocular Therapeutix(OCUL)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001493152-23-004374 Act: 34 Size: 88 KB 网页链接
产业链观察2022-09-27 18:47
药闻▶$Ocular Therapeutix(OCUL)$ 宣布 OTX-TKI 用于治疗湿性 AMD 的美国 1 期临床试验的 7 个月中期数据:
- OTX-TKI 的耐受性良好，并显示出良好的安全性，没有发生与药物相关的眼部或全身严重不良事件（SAEs）。
- OTK-TKI治疗的受试者和Aflibercept治疗的受试者在7个月...
全球新药浪潮2022-05-10 22:30
OCUL DEXTENZA Net Product Revenue $12.5M.
Guiding DEXTENZA Annual Net Product Revenue between $55M to $60M.
Topline Data from OTX-TKI for the Treatment of Wet AMD Anticipated in Q3
Cash and cash equivalents $145M.
Affamed的合作伙伴。$Ocular Therapeutix(OCUL)$
产业链观察2021-12-06 20:51
药闻▶2021年12月6日，专注于眼部疾病和病症的创新疗法的配方、开发和商业化的生物制药公司$Ocular Therapeutix(OCUL)$ 今天宣布其用于短期治疗干眼症的OTX-DED（地塞米松眼药水）的2期临床试验取得了积极的初步结果。
Ocular Therapeutix(OCUL)03-07 05:12
$Ocular Therapeutix(OCUL)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001558370-23-002908 Act: 34 Size: 11 MB 网页链接
Ocular Therapeutix(OCUL)03-07 05:12
$Ocular Therapeutix(OCUL)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-23-028993 Act: 34 Size: 319 KB 网页链接
Ocular Therapeutix(OCUL)03-07 05:18
$Ocular Therapeutix(OCUL)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001104659-23-029005 Act: 33 Size: 81 KB 网页链接
Ocular Therapeutix(OCUL)02-10 00:42
$Ocular Therapeutix(OCUL)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-23-016612 Act: 34 Size: 13 KB 网页链接
产业链观察2021-10-22 21:14
药闻| 2021年10月22日，专注于眼部疾病和病症的创新疗法的配方、开发和商业化的生物制药公司$Ocular Therapeutix(OCUL)$今天宣布了其用于治疗干眼症(DED)的OTX-CSI(环孢素管内插管)2期临床试验的初步结果。
OTX-CSI的2期临床试验是在美国进行的，是一项随机、双盲、多中心、载体控制的临床试验...
Ocular Therapeutix(OCUL)02-09 08:36
$Ocular Therapeutix(OCUL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-014683 Size: 5 KB 网页链接
Ocular Therapeutix(OCUL)03-07 05:18
$Ocular Therapeutix(OCUL)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001104659-23-029005 Act: 33 Size: 81 KB 网页链接查看全文
Ocular Therapeutix(OCUL)03-07 05:12
$Ocular Therapeutix(OCUL)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-23-028993 Act: 34 Size: 319 KB 网页链接查看全文
Ocular Therapeutix(OCUL)03-07 05:12
$Ocular Therapeutix(OCUL)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001558370-23-002908 Act: 34 Size: 11 MB 网页链接查看全文
Ocular Therapeutix(OCUL)02-13 19:18
$Ocular Therapeutix(OCUL)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001493152-23-004374 Act: 34 Size: 88 KB 网页链接查看全文
Ocular Therapeutix(OCUL)02-10 00:42
$Ocular Therapeutix(OCUL)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-23-016612 Act: 34 Size: 13 KB 网页链接查看全文
Ocular Therapeutix(OCUL)02-09 08:42
$Ocular Therapeutix(OCUL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-014684 Size: 5 KB 网页链接查看全文
Ocular Therapeutix(OCUL)02-09 08:42
$Ocular Therapeutix(OCUL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-014685 Size: 5 KB 网页链接查看全文
Ocular Therapeutix(OCUL)02-09 08:42
$Ocular Therapeutix(OCUL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-014686 Size: 5 KB 网页链接查看全文
Ocular Therapeutix(OCUL)02-09 08:36
$Ocular Therapeutix(OCUL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-014678 Size: 5 KB 网页链接查看全文
Ocular Therapeutix(OCUL)02-09 08:36
$Ocular Therapeutix(OCUL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-014683 Size: 5 KB 网页链接查看全文
$Ocular Therapeutix(OCUL)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001104659-23-029005 Act: 33 Size: 81 KB 网页链接
$Ocular Therapeutix(OCUL)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-23-028993 Act: 34 Size: 319 KB 网页链接
$Ocular Therapeutix(OCUL)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001558370-23-002908 Act: 34 Size: 11 MB 网页链接
$Ocular Therapeutix(OCUL)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001493152-23-004374 Act: 34 Size: 88 KB 网页链接
$Ocular Therapeutix(OCUL)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-23-016612 Act: 34 Size: 13 KB 网页链接
$Ocular Therapeutix(OCUL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-014684 Size: 5 KB 网页链接
$Ocular Therapeutix(OCUL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-014685 Size: 5 KB 网页链接
$Ocular Therapeutix(OCUL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-014686 Size: 5 KB 网页链接
$Ocular Therapeutix(OCUL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-014678 Size: 5 KB 网页链接
$Ocular Therapeutix(OCUL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-014683 Size: 5 KB 网页链接